[Hypogonadotrophic hypogonadism and anosmia: Kallman's syndrome].
Three male adolescents with hypogonadotropic hypogonadism and anosmia (Kallmann Syndrome) and treated with testosterone enantate are presented. The type of inheritance, the importance of others clinical signs and symptoms in an early diagnosis, variations in the response of gonadotropins and prolactin to LHRH and chlorpromazine. The optimal treatment schedule with testosterone for these patients seems to be intramuscular testosterone enantate 200 mg at two weeks intervals. Longer intervals produce less satisfactory responses.
Burgueño
M
M
Burrows
R
R
Muzzo
S
S
D000293:Adolescent; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D000857:Olfaction Disorders / Q000188:drug therapy*; D013577:Syndrome; D013739:Testosterone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; C004648:testosterone enanthate
Hipogonadismo hipogonadotrófico y anosmia: síndrome de Kallmann.